26 May 2013
Keywords: Seattle Genetics, Abbott Labs, ADC collaboration, Oncology targets
Article | 24 October 2012
US biotech firm Seattle Genetics (Nasdaq: SGEN) says it has expanded its antibody-drug conjugate (ADC) collaboration with health care major ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 October 2012
25 October 2012
24 May 2013
© 2013 thepharmaletter.com